Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer

BACKGROUND: The role of postoperative radiotherapy (PORT) in patients with clinical stage III-N2 (cIII-N2) non-small cell lung cancer (NSCLC) treated with induction chemotherapy and surgical resection with persistent ypN2 disease is not well-established. METHODS: We retrospectively reviewed a prospe...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Thorac Surg
Auteurs principaux: Brandt, Whitney S., Yan, Wanpu, Leeman, Jonathan E., Tan, Kay See, Park, Bernard J., Adusumilli, Prasad S., Bott, Matthew J., Molena, Daniela, Isbell, James, Chaft, Jamie, Rimner, Andreas, Jones, David R.
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136648/
https://ncbi.nlm.nih.gov/pubmed/29807005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2018.04.064
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires